• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value

The 150-year-old drugmaker is the first company in health care to hit the milestone.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Corporations, Dave Ricks, Diabetes, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), Insulin, Lilly Endowment, Prices (Fares, Fees and Rates), Stocks and Bonds, Trump, Donald J
←9 Books That Showcase The Legacy Of Hip Hop
Inside Mai Pham’s Re-Created Childhood Bedroom: From YouTube Dreams To Family Healing→

More posts

  • 24 Hours With Nike’s C.E.O. as He Races to Win Back the Sports World

  • A Wink, a Nod or a Duck: The Secrets Behind Car Owners’ Secret Handshakes

  • A Crypto Coin Is Gobbling Up U.S. Treasuries

  • At a lobster-themed event for AI enthusiasts, exuberance with a side of cocktail sauce

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube